Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

 

International Congress of Parkinson’s Disease and Movement Disorders ®

Congress
Main Content

2023 MDS Awardees

 

 

View recipients: 

 


View the 2023 Awards Brochure 

View brochure PDF

Honorary Membership Awards

The MDS Honorary Membership Award Program recognizes individuals who have made extraordinary contributions to the field of Movement Disorders or otherwise to the Society. Recipients of this prestigious award shall be entitled to lifetime MDS Membership.

Irene Litvan

Dr. Litvan is the Tasch Endowed Professor of Parkinson Disease at the University of California San Diego (UCSD) and Director of the UCSD Parkinson and Other Disorder Movement Disorder Center (Parkinson Foundation Center of Excellence, DLB Research Center of Excellence and CurePSP Care Center). For over 30 years, she has led and participated in several multicenter studies or international Task Forces to develop clinical and neuropathologic diagnostic criteria for all parkinsonian and/or dementia neurodegenerative disorders (PSP, CBD, MSA DLB, PD, PD-MCI, PDD, Prodromal PD), diagnostic biomarkers research, symptomatic and biologic therapeutic trials, and epidemiologic, genetic and clinicopathologic correlation studies.

She was awarded the National Institutes of Health Merit Award, American Academy of Neurology Movement Disorder Research Award and elected National Academy of Medicine of Uruguay Foreign Scientist. She has published more than 400 peer-reviewed articles and chapters, co-edited 4 books and ranked top 1% of most cited scientific investigators (Web of Science) for the past 4 years. She is an active member of the International Parkinson and Movement Disorders Society (MDS), was a member or led many committees, study groups, was PAS Education Chair and is Movement Disorders Society (MDS) Treasurer.

Nobutaka Hattori

Dr. Hattori received an MD degree from Juntendo University in 1985. He became a resident in the Department of Neurology of Juntendo Hospital. After finishing residency training at Juntendo Hospital, he was appointed as an assistant professor of neurology at Juntendo University in Tokyo, Japan, in 1988. He was certified by the Japanese Neurological Society in 1989. He was admitted to a graduate school of Juntendo University in 1990. Dr. Hattori trained in molecular biology at the Department of Biomedical Chemistry of Nagoya University from 1990 to 1993. Then Dr. Hattori graduated from graduate school in 1994. Dr. Hattori was appointed as the assistant professor of neurology at Juntendo University School of Medicine in 1995 and then became an associate professor of neurology in 2003. Finally, Dr. Hattori became the professor and chairman of neurology at Juntendo University School of Medicine in 2006. Dr. Hattori is an active member and director of the Japanese Neurological Association and a corresponding fellow of the American Neurological Association. Dr. Hattori is also a full member of the Movement Disorders Society and MDS-AOS chair (2015-2017). And Dr. Hattori is a member of the International Executive Committee of MDS (2021-2025). Dr. Hattori serves as an ad hoc reviewer of many international journals. 

As a scientist as well as a clinician, Dr. Hattori has been interested in the etiology and pathogenesis of Parkinson’s disease. Dr. Hattori found a decrease in the amount of complex I in the substantia nigra of Parkinson’s disease patients (Ann Neurol 1992). More recently, Dr. Hattori and his collaborators identified the disease gene for an autosomal recessive form of young onset familial Parkinson’s disease and named the gene “parkin”. This is the second form of familial Parkinson’s disease in which the disease gene was identified.

In addition, Dr. Hattori and his collaborators found that the gene product, parkin, is directly linked to the ubiquitin-proteasome pathway as a ubiquitin ligase and is involved in mitophagy. This discovery suggested that the protein degradation system is involved in the pathogenesis of not only the monogenic form of Parkinson’s disease but also sporadic Parkinson’s disease. In addition, Dr. Hattori and his colleagues have identified novel genes, CHCHD2 and PSAP (Lancet Neurol 2015; Brain 2020). CHCHD2 and PSAP products are associated with mitochondrial and lysosomal functions, respectively. In addition, Dr. Hattori and his colleagues are interested in the relationship between biomarkers and PD.  Dr. Hattori and his colleagues have developed real-time quaking-induced conversion combined with immunoprecipitation, a method that enables the detection of α-synuclein seeds from the serum of patients with synucleinopathies. This method can lay the foundation for the biological diagnosis of synucleinopathies (Nat Med 2023). 

Dr. Hattori obtained several awards, including the Award for the Japanese Society of Neurology and the Minister of Education Award. Dr. Hattori is the first Japanese to be selected as an honorary member of the Spanish Neurological Society.  Dr. Hattori has published > 1,000 scientific papers and has an h-factor of 87 with 41,683.

Public Service Award

The Public Service Award recognizes an individual or organization that exhibits the highest standard of excellence, dedication, and accomplishment in public engagement within the field of Movement Disorders working toward public outreach and patient betterment. 

Ginger Irvine

The 2023 MDS Public Service Awardee is bestowed upon Ginger Irvine for her work on behalf Advocacy for Neuroacanthocytosis Patients (NA Advocacy), in London, United Kingdom.

”I am honoured and grateful to receive the 2023 Movement Disorder Society (MDS) Public Service Award on behalf of the Advocacy for Neuroacanthocytosis Patients (NA Advocacy). MDS was a kind supporter of a number of our Symposia.

The neuroacanthocytosis (NA) patients are likely diagnosed with either VPS13A syndrome (most commonly known as Chorea-acanthocytosis) or XK syndrome (most commonly known as McLeod disease). The two conditions are extremely similar, with the difference being in the age of manifestation and the gender distribution. The most common symptoms are uncontrolled muscle movements such as involuntary twisting, facial tics, biting of tongue, cheek and lips; unsteady gait, muscle weakness and/or atrophy; seizures; slurred speech or inability to speak; and/or cognitive difficulties such as impaired memory.

My husband Glenn and I were introduced to a field of endeavour we never expected to enter when our daughter, Alex, started to manifest symptoms around the mid-90s. There was very little knowledge back then and the journey to diagnosis lasted four years. With neither of us having a medical background, our experiences over the past 25 years have brought new knowledge and understanding and a whole lot of respect for the wider medical world globally.

We partnered with Dr. Adrian Danek in Munich to develop the first International Symposium for NA syndromes in 2002 in Seeon, Germany. Since then, the Symposium takes place biennially and from the eighth edition in 2016, has been open to patients, their families and carers.

The pandemic saw new challenges (delay by one year to 2021) but also some opportunities for our community, including the tenth (and first virtual) Symposium. And this year, on 15 September we are pleased to reunite again in person, in Germany for the 11th edition, with a packed agenda of scientific presentations and posters, as well as sessions involving the patients, their families and carers.

It was in 2009 when we founded NA Advocacy as a registered charity. With the help and support of many, for which we are very grateful, we are pleased to have been able to award grants which contributed to advancing the research into the NA syndromes.

We are committed to encouraging and supporting research further, and to continue the work of my late husband, we founded the Glenn Irvine prize in 2020, kindly supported by two of our long-term contributors. This is awarded to young scientists with a research interest in NA syndromes.

We consider ourselves very fortunate to have the chance to work with all the clinicians and researchers who are heading the labs and projects which will lead to better treatments and possibly cures for these rare movement disorders.

Spreading the word, sharing patients’ stories and ideas, and enabling meetings to bring the experts together has made it possible for us to present a united front to the world."

Distinguished Service Awards 

The President’s Distinguished Service Award is chosen directly by the MDS President in recognition of long and distinguished service to the International Parkinson and Movement Disorder Society (MDS). 

Joaquim Ferreira

Joaquim Ferreira completed his medical degree and PhD in Neurology at the University of Lisbon.  He became interested in movement disorders while pursuing his medical degree and later undertook a Clinical Pharmacology fellowship with Prof. Olivier Rascol in Toulouse, France. His major research interests are neuropharmacology, Parkinson’s disease, dystonia and Huntington’s disease. 

Prof. Ferreira is currently Professor of Neurology and Clinical Pharmacology and Head of the Laboratory of Clinical Pharmacology and Therapeutics at the Faculty of Medicine, University of Lisbon.

He is also a Group Leader at the Instituto de Medicina Molecular and the head of CNS- Campus Neurológico Sénior, a movement disorders center dedicated to the multidisciplinary rehabilitation of people with Parkinson’s disease and other movement disorders.  

He was previously Chair of the Education Committee and the MDS-European Section and most recently served MDS for the past two years as the first-ever Chair of the new Communications Oversight Committee (COC).

Veronica Santini

Veronica Santini completed her medical degree in Neurology at Boston University School of Medicine and is now the Clinical Chief of Movement Disorders and Director of the Comprehensive Parkinson Disease Program at Yale University.

Prior to joining the faculty at Yale, she directed the Stanford Multidisciplinary Huntington’s Disease and Genetic Ataxia Clinic, an HDSA Center of Excellence, where she oversaw a large and dedicated team of specialists providing truly holistic, patient-centered care.

During her time at both Stanford and Yale, Dr. Santini has been an influential educator for neurology residents, fellows, and expert learners as a member of the Congress Scientific Program Committee and Chair of the MDS Continuing Medical Education Committee.

Presidential Lecture Awards

Caroline Tanner, Stanley Fahn Lecture Award

Caroline M. Tanner, MD, PhD, FAAN, is a Professor of Neurology and Vice Chair for Clinical Research at the Weill Institute for Neurosciences, University of California – San Francisco. Dr. Tanner’s clinical practice specializes in movement disorders. She joined MDS at its inception, has served on the International Executive Committee, and has chaired or served on numerous other committees. Her research interests include descriptive epidemiology, environmental and genetic determinants, biomarkers, early detection, nonmotor disease features and clinical trials for all stages of disease. Dr. Tanner and her colleagues have identified associations between exposures including certain pesticides, solvents and persistent environmental pollutants and increased risk of Parkinson’s disease, and identified gene-environment interactions.

Her current work includes serving as the principal investigator of the Fox Insight online study and as a member of the leadership team of the Parkinson’s Progression Markers Initiative (PPMI) study. She is co-principal investigator of the Trial of Parkinson’s and Zolendronate (TOPAZ ), a completely home-based study focused on fracture prevention in people with PD. She has been fortunate to serve as mentor to talented students from many countries, who themselves are now leading researchers and educators worldwide.  Her honors include the University of California - Berkeley Alumni Excellence in Achievement Award (2008), AAN Movement Disorders Research Award (2012), the White House Champions of Change for Parkinson’s (2015), International Parkinson and Movement Disorder Society Honorary Member (2020), the Tom Isaacs Award - Cure Parkinson’s Trust  & Van Andel Institute (2020), the Robert A. Pritzker Prize – Michael J Fox Foundation (2020), the Advocacy Award - Parkinson’s Policy Forum (2021) and the Robert A. Wartenberg lectureship – American Academy of Neurology (2021).

Andrew Singleton, C. David Marsden Lecture Award

Andrew received his B.Sc. from the University of Sunderland, UK and his Ph.D. from the University of Newcastle upon Tyne, UK. His research initially focused on genetic determinants of Alzheimer’s disease and dementia with Lewy bodies. His postdoctoral studies were spent at the Mayo Clinic in Jacksonville Florida. Andrew moved to the National Institute on Aging at NIH in 2001, becoming a principal investigator in 2002. In 2007 Andrew became a tenured senior investigator, in 2008 he became the Chief of the Laboratory of Neurogenetics, and in 2016 he was named an NIH Distinguished Investigator. In 2021 Andrew was named the Director of the new Center for Alzheimer’s and Related Dementias at NIH.

Andrew has published more than 700 articles on a wide variety of topics. His group works on the genetic basis of neurodegenerative disorders. The goal of this research is to identify genetic variability that causes or contributes to disease and to use this knowledge to understand the molecular processes underlying disease. His laboratory has been a leader in the identification of a number of genetic causes and risk factors for neurodegenerative disease, including mutations in LRRK2, PRKRA, TREM2, ITPR1, SLC52A2, and SNCA multiplication mutations, and approximately 100 novel risk loci for PD.

Andrew currently is a member of numerous scientific advisory and editorials boards. Andrew was awarded the Boehringer Mannheim Research Award in 2005, the NIH Director’s Award in 2008 and again in 2016, and the Annemarie Opprecht Award for Parkinson’s disease research in 2008. In 2012 he became the first person to win the Jay van Andel Award for Outstanding Achievement in Parkinson’s Disease Research. In 2017 Andrew was awarded the American Academy of Neurology Movement Disorders Award and an Honorary Doctorate from his alma mater, the University of Sunderland. In 2019 Andrew was awarded the Robert A. Pritzker Prize for Leadership in Parkinson’s Research.

Junior Awards

MDS Junior Awards are presented in recognition of significant contribution to clinical or basic science research in the field of Movement Disorders, to qualified individuals submitting top ranked abstracts for the International Congress.

Steve Joza, Canada

Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter study

Ayami Okuzumi, Japan

IP-RT-QuIC Identify Disease-Specific Alpha-Synuclein Seeds in serum from patients with syncleinopathy

Article of the Year Awards

The Movement Disorders and Movement Dsiorders Clinical Practice Research and Review Articles of the Year awards were chosen by the Journal’s Editors and Editorial Board to recognize quality work being submitted by authors and the important articles published in the Journal. The winning articles were selected from five finalists in each category, all which shared a high scientific level and interest.

2023 MDJ Research Article of the Year: Long-Duration Response to Levodopa, Motor Learning, and Neuroplasticity in Early Parkinson's Disease

Giorgia Sciacca, MD, PhD; Giovanni Mostile, MD, PhD; Ivano Disilvestro, TNP; Giulia Donzuso, MD, PhD; Alessandra Nicoletti, MD; Mario Zappia, MD
Volume 38 Issue 4; DOI: 10.1002/mds.29344

Read article

 

2023 MDJ Review Article of the Year: How Does Deep Brain Stimulation Change the Course of Parkinson's Disease?

Philipp Mahlknecht, MD, PhD, Thomas Foltynie, MD, PhD, Patricia Limousin, MD, PhD, and Werner Poewe, MD
Volume 37 Issue 8; DOI: 10.1002/mds.29052

Read article

2023 MDCP Research Article of the Year: Have We Forgotten What Tics Are? A Re-Exploration of Tic Phenomenology in Youth with Primary Tics

Christelle Nilles MD, Davide Martino MD, PhD, Julian Fletcher BA, Tamara Pringsheim MD
Volume 10 Issue 5; DOI: 10.1002/mdc3.13703

Read article

 

2023 MDCP Review Article of the Year: α-Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies using Cerebrospinal Fluid – a Systematic Review and Meta-Analysis

Anna Grossauer MD, Greta Hemicker, Florian Krismer MD, PhD, Marina Peball MD, PhD, Atbin Djamshidian MD, PhD, Werner Poewe MD, Klaus Seppi MD, Beatrice Heim MD, PhD
Volume 10 Issue 5; DOI: 10.1002/mdc3.13710

Read article

Reviewer Awards

The Editors of Movement Disorders and Movement Disorders Clinical Practice are pleased to recognize the top reviewers for their service in 2022. These reviewers each contributed more than 7 reviews in 2022, submitting their detailed reviews on time and with valuable comments for the editors and authors.

Movement Disorders Journal Reviewers

Michael Bartl
Yaroslau Compta
Mark Edwards
Alfonso Fasano
Tim Fieblinger
Ziv Gan-Or
Franziska Hopfner
Jan Kassubek
Vikas Kotagal
Kishore Raj Kumar
Mohammad Mansournia
Davide Martino
Nikolaus McFarland
Tiago Mestre
Alastair Noyce
Lucilla Parnetti
Ronald Postuma
Nicholas Wood
Mary Xylaki
Michael Zech

Movement Disorders Clinical Practice Reviewers

Roberto Erro
Alfonso Fasano
Jacky Ganguly
Anna Latorre
Abhishek Lenka
Francesca Magrinelli
Hugo Morales-Briceño
Francesca Morgante
Sanjay Pandey
Shweta Prasad
Malco Rossi
Miguel Wilken

LEAP Graduates 

The MDS LEAP program provides a leadership training program to support the growth, development and success of young movement disorder specialists. This 12-month program encompasses the development of leadership skills through mentored development and a didactic skills training program.

MDS-AOS Region

Divya K P, India
Elie Matar, Australia
Jung Hawn Shin, South Korea
Eloise Watson, New Zealand

MDS-ES Region

Vanessa Carvalho, Portugal
Natalia Szejko, Poland
Anne Weissbach, Germany
Rezzak Yilmaz, Turkey

MDS-PAS Region

Mitra Afshari, USA
Erik González Delgado, Bolivia
Carolina Gorodetsky, Canada
Sara Schaefer, USA

MDS-AS Region

Eman Abdeldayem, Egypt
Walaa Kamel ElSayed, Egypt
Adrian Mugenyi Kakooza, Uganda
Louis Vlok, South Africa

Learn more about the LEAP class of 2022:

View profiles

2023 Travel Grants

The International Parkinson and Movement Disorder Society proudly welcomes the 2023 Travel Grant Award recipients to the International Congress.

Saltanat Abdraimova
Patrick Acuna
Mohammad Adil
Ayush Agarwal
Daniela Aguila-Godinez
Mohammad Ahmad
Md Zainul Ali
Reghu Anandapadmanabhan
Sabbir Ansari
Hayslenne Andressa Araújo
Eduardo Argüelles-González
Shivani Arjun
Barkat Babar
Sattwika Banerjee
Pedro Barbosa
Lorena Barcelos
Purba Basu
Asit Bayen
Sara Becker
Meriem Ben Hafsa
Ahana Bhattacharya
Meredith Bock
Ali Buckland
Lingxiao Cao
Marcia Castillo
Sergio Castillo-Torres
Girish Chandran
María Belén Charra Castellani
Koustav Chatterjee
Sayan Chatterjee
Yen-chung Chen
Shuqi Chen
Chen Chen
Yangfan Cheng
Ajith Cherian
Xiaosa Chi
Ko-Eun Choi
Ha Nyeong Choi
Zoe Yuen-Kiu Choi
Shatabdi Choudhury
Supriyo Choudhury
Harshadkumar Chovatiya
Natalia Chunga
Mariana Costa
Ivonne Cruz
Thuong Dang
Mohammad Darabseh
Animesh Das
Indrani Datta
Danilo de Faria
Xiao Deng
Soaham Desai
Devangi Desai
Debjyoti Dhar
Ariadna Domínguez-García
Henrique Dourado
Alexia Duarte
Alfand Marl Dy Closas
Arunmozhimaran Elavarasi
Tarek Elshourbagy
Bruna Luísa Fadel
Rifaldy Fajar
Lauren Fanty
Jacky Ganguly
Virginia Gao
Jose Garcia
Surabhi Garg
Divyani Garg
Kanwaljeet Garg

Talyta Grippe
Richa Gupta
Yismet Guzman
Lauren Hammer
Ana Jimena Hernández-Medrano
Chin Pong Ho
Vikram Holla
Jia Wei Hor
Pei Huang
Aizhamal Iliazova
Mariam Isayan
Jessie Jacobson
Lubna Jafri
Soham Jagtap
Swapnil Jain
Ivan Jeremia
Lirong Jin
Min-Gi Jo
Stephen Joza
Rasulberdi Juraev
H J Jyothi
Rauan Kaiyrzhanov
Keita Kakuda
Divya Kalikavil Puthanveedu
Sneha Kamath
Daiki Kamiyama
Hikaru Kamo
Sungwoo Kang
Khushboo Kanojia
Shirpa Kartik
Oksana Kasimova
Serdar Kazanci
Ignacio Juan Keller Sarmiento
Vikram Khardenavis
Sanjeev Kharel
Dharmendra Khatri
Seoyeon Kim
Ravi Kota
Geetanjali Kuanar
Sonali Priyadarsinee Kuanar
Pardeep Kumar
Mrina Kumar
In hee Kwak
Sagar lavania
Seungmin Lee
Jeongjae Lee
Xin-Yi Li
Jun Li
Gustavo Lima
Junyu Lin
Zhiru Lin
Luisa Lira Juárez
Clarice Listik
Zhu Liu
Camila Lobo
Joel Maamary
Syeda Madiha
Chitaranjan Mahapatra
Pooja Mailankody
Suchismita Majumdar
Moulika Mandal
Sarah Marmol
Vaibhav Mathur
Rustambek Matmurodov
Meera Matta
Maria de los Angeles Medrano-Delgado
Anish Mehta
Biswamohan Mishra

Mariana HG Monje
Lee-Anne Morris
Bekzod Muminov
Daniela Munoz
Sai Nagaratnam
Chakradhar Nagireddy
Olim Naimov
Jean-Francois Nankoo
Jessica Ng
Huu Dat Nguyen
Katia Nobrega
Eric Noyes
Rajeev Ojha
Diego Orcioli-Silva
Ruwei Ou
Samir Panda
Ankit Panjwani
Pankaj Pankaj
Aditi Panwar
Kwan Young Park
Jacy Parmera
Artur José Paulo
Sujith Pavan
David Pellerin
Gabriela Pereira
Laura Pesantez Pacheco
Khachik Petrosyan
Appasone Phoumindr
Warongporn Phuenpathom
Kanchana Pillai
Gabriel Pinilla-Monsalve
Dana Pourzinal
Gala Prado-Miranda
Lina Quintero-Giraldo
Vineeth Radhakrishnan
Divya Radhakrishnan
Sanskriti Rai
Sakthi JayaSundar Rajasekar
Rakesh Rajput
Daniel Rebolledo Garcia
Andrés Regalado Mustafá
Shoaib ur Rehman
Paula Reyes-Pérez
Lilia Rotaru
Akash Roy
Heeda Rozario
María Agustina Ruiz Yanzi
Surachet Rujirussawarawong
Jyoti Rungta
Paula Saffie-Awad
Arti Saini
Arushi Saini
Javlon Salimjonov
Stephanie Sandoval-Pistorius
Elba Santiago
Swagata Sarkar
Filipe Sarmento
Ruta Savaj
Jie Ping Schee
Konstantin Senkevich
Shreya Shah
Vikas Sharma
Neetika Sharma
Sakshi Shukla
Kritee Shukla
Inder Singh
Harshdeep Singh
Ranbir Singh
Rakesh Singh

Deepika Singh
Miriam Soares
Akhilesh Sonakar
Carolina Souza
Neeharika Sriram
Siao-Chu Su
Dongning Su
Junyan Sun
Valerie Sutanto
Christina Swan
Vishnu Swarup
Natalia Szejko
Ariany Tahara
Yi Wen Tay
Phanutgorn Techa-angkoon
Daniel Teixeira-dos-Santos
Tzi Shin Toh
Mellany Tuesta Bernaola
Ornanong Udomsirithamrong
Alo Uppar
Mila Hapsari Utami
Chetan Vekhande
Asish Vijayaraghavan
Sasivimol Virameteekul
Aayushi Vishnoi
Kavadisseril Vysakha
Bo Wang
Kyung Ah Woo
Takashi Yamaguchi
Tianmi Yang
Sijia Yin
Andrea Yoo
Cherry Yu
Jun Yu
Sam Yuen
Eliza Zhunusova
Siao-Chu Su
Dongning Su
Junyan Sun
Valerie Sutanto
Christina Swan
Vishnu Swarup
Natalia Szejko
Ariany Tahara
Yi Wen Tay
Phanutgorn Techa-angkoon
Daniel Teixeira-dos-Santos
Tzi Shin Toh
Mellany Tuesta Bernaola
Ornanong Udomsirithamrong
Alo Uppar
Mila Hapsari Utami
Chetan Vekhande
Asish Vijayaraghavan
Sasivimol Virameteekul
Aayushi Vishnoi
Kavadisseril Vysakha
Bo Wang
Kyung Ah Woo
Takashi Yamaguchi
Tianmi Yang
Sijia Yin
Andrea Yoo
Cherry Yu
Jun Yu
Sam Yuen
Eliza Zhunusova

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice

Cookie Settings

  • Your Privacy

  • Strictly Necessary

  • Performance

  • Targeting/Advertising

Your Privacy

When you visit a website, it may collect information about your browser, your preferences, or your device to make the website work as you expect it to. This information is collected in the form of cookies. The information collected does not identify you directly, but it can give you a more personalized website experience. The following describes the different types of cookies we are using and gives you the option to not allow some types of cookies. Click on the category headings to learn more and change your default cookie settings. Please note that blocking some types of cookies may impact your website experience.

Strictly Necessary

Always Enabled

These cookies are essential in order to enable you to move around the website and use its features. Without these cookies, website services, such as remembering your shopping cart items, cannot be provided. We are unable to turn these cookies off in the system. While you may be able to set your browser to block or alert you about these cookies, some parts of the website will not function without them.

Modules:

Performance

These cookies collect anonymous information on how people use the website: website visits, traffic sources, click patterns and similar metrics. They help us understand what pages are the most popular. All of the information collected is aggregated and therefore anonymous. If you do not allow these cookies, we will not know when you have visited our website.

Modules:

Targeting/Advertising

These cookies collection information about your browsing habits in order to make advertising more relevant to you and your interests. They are set up through our advertising partners, who compile your interests and target you with relevant ads on other websites or platforms. If you do not allow these cookies, you will not experience our targeted advertising on other places throughout the web.

Modules: